Table 2: Patient characteristics and exposures and their association with positive COVID-19 test results.
|
|
Positive for exposure |
COVID-19 Positive N = 22 |
|
|
|
|
Exposure |
N (%) |
POSITIVE N (%) |
NEGATIVE N (%) |
OR (95% CI) |
P-VALUE |
|
Significant Medical History* |
73 (46%) |
6 (8.2%) |
16 (18.4%) |
0.40 (0.15-1.08) |
0.07 |
|
Sick Contact |
47 (37%) |
16 (34.0%) |
6 (7.5%) |
6.37 (2.28-17.79) |
0.0002 |
|
Travel |
13 (14%) |
4 (30.8%) |
12 (14.6%) |
2.59 (0.69-9.78) |
0.22 |
*Significant medical history included: Patient 1: PCOS with insulin resistance; patient 2: Mild, intermittent asthma; Patient 3: Moderate, persistent asthma; Patient 4: Malignant brain neoplasm; Patient 5: Hyperthyroidism; and patient 6: previous seizure.